If you experience persistent difficulties with your pen device or unexplained hyperglycaemia, contact your healthcare provider promptly
Morava E, Baumgartner M, Patterson M, Rahman S (eds.)
FDA GLP-1 approval to reduce cardiovascular risk in obesity World Health Organization 2025 guideline on GLP-1 medicines for obesity NIH / PubMed cardiovascular and kidney outcomes of GLP-1 in older adults The Lancet eClinicalMedicine GLP-1 use and lower dementia risk in older adults The BMJ gastrointestinal side effects of GLP-1 medications The Lancet Healthy Longevity GLP-1 and sarcopenia risk in frail older adults NIH / PubMed dehydration and GLP-1 therapy ScienceDirect long-term safety considerations for GLP-1 use ScienceDirect monitoring guidance for GLP-1 medications MDWatch Weight-Loss Program See if a GLP-1 is right for you Get a personalized plan from board-certified medical providers who treat seniors every day
Zhang Z, Gao J, Yuan L, Duan B, Yang H, Ma L
a simple pen and paper notebook works perfectly, though many people find calorie-counting apps helpful
The evidence here is even thinner than for VR
